Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 02-2014 | 12-2013 | 03-2013 | 02-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 2,720 | 1,190 | N/A | 1,190 |
| Marketable Securities | N/A | 730 | 3,590 | N/A | 3,590 |
| Receivables | N/A | 970 | 830 | N/A | 830 |
| Inventories | N/A | 360 | 220 | N/A | 220 |
| Other current assets | 0 | 330 | 40 | 0 | 40 |
| TOTAL | $N/A | $5,110 | $5,870 | $N/A | $5,870 |
| Non-Current Assets | |||||
| PPE Net | N/A | 10 | 10 | N/A | 10 |
| Other Non-Current Assets | 0 | 19,400 | 6,300 | 0 | 6,300 |
| TOTAL | $N/A | $19,410 | $6,310 | $N/A | $6,310 |
| Total Assets | $N/A | $24,530 | $12,190 | $N/A | $12,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,060 | 700 | 0 | 700 |
| Other current liabilities | N/A | 2,710 | 1,740 | N/A | 1,740 |
| TOTAL | $N/A | $4,780 | $2,450 | $N/A | $2,450 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $0 | $N/A | $N/A | $0 |
| Total Liabilities | $N/A | $4,780 | $2,450 | $N/A | $2,450 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 221 | N/A | N/A | 152 | N/A |
| Common Shares | N/A | 44,630 | 28,970 | N/A | 28,970 |
| Retained earnings | N/A | -27,990 | -20,080 | N/A | -20,080 |
| Other shareholders' equity | 0 | 390 | 420 | 0 | 420 |
| TOTAL | $N/A | $19,740 | $9,740 | $N/A | $9,740 |
| Total Liabilities And Equity | $0 | $24,520 | $12,190 | $0 | $12,190 |